Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Robert Watson, a NIHR Academic Clinical Fellow in the laboratory of Benjamin Fairfax in the Department of Oncology. Robert was successful in his application for a CRUK pre-doctoral research bursary.

Pre-doctoral research bursaries are awarded biannually by Cancer Research UK to "provide short-term funding to allow clinicians and other health professionals to get involved in research projects early in their career". This scheme was ideal for Robert Watson, a junior doctor with an interest in academic research. He is currently taking a year out from his clinical training to conduct research in the laboratory of Benjamin Fairfax at the MRC WIMM, and is interested in applying for a PhD at a later date. "This CRUK grant will support my research this year" explains Rob "It will give me a chance to experience research and develop my skills, and hopefully gather preliminary data that will help me apply for a PhD".

The laboratory of Dr Benjamin Fairfax is examining the genetic changes that accompany the treatment of cancer with immunotherapies. During his time in the lab, Robert will be using sequencing techniques to investigate changes to the T cell repertoire during checkpoint inhibitor treatments. "I am very keen to work in the area of immunoncology and to further develop my skills in genetic medicine and computational biology, so this projects fits well with the lab's strategy and my own personal aims", says Robert. The successful bid will provide £25,000 towards the project's research expenses.

Similar stories

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.